0

IGF-1R Inhibitor PQ401 Inhibits Osteosarcoma Cell Proliferation, Migration and Colony Formation

Baochang Qi, Riping Zhang, Rujun Sun, Mian Guo, Maomao Zhang, Guojun Wei, Lei Zhang, Shan Yu, Hui Huang

Int J Clin Exp Pathol. 2019 May 1;12(5):1589-1598.

PMID: 31933976

Abstract:

IGF-1R is expressed abnormally in osteosarcoma (OS) and could participate in its progression. In this study, we aimed to explore the effect of the IGF-1R inhibitor PQ401 as a treatment for OS. The relative expression of IGF-1R in OS patient tumors and the U2OS cell line were determined by qRT-PCR and by accessing information in a public database. Inhibition of cell proliferation by PQ401 was determined by MTT assay. Cell migration under low concentration treatment of PQ401 was carried out by transwell and wound healing assays. PQ401 induction of OS cell apoptosis was investigated by flow cytometry. Tumorigenesis under PQ401 treatment was evaluated by a colony formation assay. Finally, downstream blockage of the IGF-1R pathway was verified by western blotting. Our results show that the expression of IGF-1R was remarkably higher in OS cells, particularly in U2OS, than in other cancer-type cell lines. The inhibition of the IGF-1R pathway by PQ401 exhibited significant anticancer activity in the U2OS cell line in not only proliferation but also migration and colony formation. In addition, PQ401 is a strong inducer of OS cell apoptosis. Furthermore, western blotting was used to demonstrate that the IGF-1R related downstream pathway, including total ERK1/2, was significantly inhibited by PQ401. Thus, IGF-1R inhibition may represent a novel treatment for OS.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP196868630-B PQ401 PQ401 196868-63-0 Price
qrcode